
浏览全部资源
扫码关注微信
1.中国医学科学院/北京协和医学院/北京协和医院内分泌科/国家卫生健康委员会内分泌重点实验室/中国医学科学院糖尿病;研究中心,北京 100730
2.中国医学科学院/北京协和医学院/北京协和医院妇产科,北京 100730
翟 笑,Email:zhaixiao1990@126.com, 研究方向:主要从事内分泌及代谢病。
肖新华,Email:xiaoxh2014@vip.163.com。
收稿:2025-07-30,
修回:2025-10-25,
纸质出版:2026-01-28
移动端阅览
翟笑,周晶,邓明群,等.妊娠期糖尿病患者血清及其新生儿脐血中脂肪因子水平与相关因素分析[J].重庆医科大学学报,2026,51(1):34-39.
Zhai Xiao,Zhou Jing,Deng Mingqun,et al.Levels of adipokines in serum of patients with gestational diabetes mellitus and umbilical cord blood of their neonates and related factors[J].Journal of Chongqing Medical University,2026,51(1):34-39.
翟笑,周晶,邓明群,等.妊娠期糖尿病患者血清及其新生儿脐血中脂肪因子水平与相关因素分析[J].重庆医科大学学报,2026,51(1):34-39. DOI: 10.13406/j.cnki.cyxb.003996.
Zhai Xiao,Zhou Jing,Deng Mingqun,et al.Levels of adipokines in serum of patients with gestational diabetes mellitus and umbilical cord blood of their neonates and related factors[J].Journal of Chongqing Medical University,2026,51(1):34-39. DOI: 10.13406/j.cnki.cyxb.003996.
目的
2
探讨妊娠期糖尿病(gestational diabetes mellitus,GDM)患者糖脂代谢状态与母婴体内脂肪因子[成纤维细胞生长因子21(fibroblast growth factor 21,FGF21)、瘦素和脂联素]水平的关系,以及孕妇血清中的脂肪因子水平与新生儿体内脂肪因子水平的关系。
方法
2
纳入2017年9月至2018年9月在北京协和医院进行定期产检检查并最终分娩的孕妇,按照GDM诊断标准分为血糖正常组(n=39)和GDM组(
n
=44)。收集一般资料,并采集孕妇足月外周血清及其新生儿脐血血清标本。测定2组孕妇生化指标,以及母婴血清中脂肪因子水平。
结果
2
①GDM组孕妇血清中FGF21水平明显高于血糖正常组[386.24(256.13,577.26) vs. 239.71(148.10,378.48) pg/mL(
P
=0.005)],GDM组新生儿脐带血中FGF21水平高于血糖正常组[74.78(63.78,106.11) vs. 52.74(49.66,65.16) pg/mL(
P
=0.160)],但差异无统计学意义;GDM组孕妇血清中瘦素水平明显高于血糖正常组[462.19(268.06~883.48) vs. 292.55(143.97~595.95) pg/mL(
P
=0.044)];脂联素在孕妇血清和脐带血中差异均无统计学意义(
P
>
0.05)。②新生儿脐血血清中FGF21水平与孕妇血清FGF21水平(
r
=0.350,
P
=0.043)、孕妇胆固醇(
r
=0.324,
P
=0.02)和孕妇脂蛋白α(
r
=0.377,
P
=0.007)呈正相关,与孕妇HOMA-IR(
r
=0.319,
P
=0.024)和瘦素水平(
r
=0.473,
P
=0.002)呈正相关。
结论
2
GDM患者血清FGF21和瘦素水平可能出现升高,并且可以明显影响新生儿脐血中FGF21水平,而新生儿脐血中FGF21水平与孕妇糖脂代谢异常相关。
Objective
2
To investigate the association between the status of glucose and lipid metabolism in patients with gestational diabetes mellitus(GDM) and the levels of adipokines(fibroblast growth factor 21[FGF21],leptin,and adiponectin) in mothers and their neonates,as well as the correlation between the levels of adipokines in serum of mothers and the levels of adipokines in their neonates.
Methods
2
Pregnant women who underwent regular prenatal examinations and finally gave birth in Peking Union Medical College Hospital from September 2017 to September 2018 were enrolled,and according to the diagnostic criteria for GDM,they were divided into normal blood glucose group with 39 women and GDM group with 44 women. General data were collected,and peripheral serum samples were collected from the pregnant women giving birth to full-term neonates,while serum samples of umbilical cord blood were collected from their neonates. Biochemical parameters were measured for the pregnant women in each group,as well as the serum levels of adipokines in both the mothers and the neonates.
Results
2
Compared with the normal blood glucose group,the GDM group had a significantly higher serum level of FGF21[386.24(256.13-577.26) pg/mL vs. 239.71(148.10-378.48) pg/mL,
P
=0.005] and a higher level of FGF21 in umbilical cord blood of neonates[74.78 (63.78-106.11) pg/mL vs. 52.74 (49.66-65.16) pg/mL,
P
=0.160]. Compared with the normal blood glucose group,the GDM group had a significantly higher serum level of leptin in the pregnant women[462.19 (268.06-883.48) pg/mL vs. 292.55(143.97-595.95) pg/mL,
P
=0.044],and there was no significant difference in the level of adiponectin in the serum of the mothers and the umbilical cord blood of the neonates between the two groups(
P
>
0.05). The serum level of FGF21 in neonatal umbilical cord blood was positively correlated with the serum level of FGF21 in pregnant women(
r
=0.350,
P
=0.043) and the levels of cholesterol(
r
=0.324,
P
=0.02),lipoprotein α(
r
=0.377,
P
=0.007),HOMA-IR(
r
=0.319,
P
=0.024),and leptin (
r
=0.473,
P
=0.002) in the mothers.
Conclusion
2
There might be increases in the serum levels of FGF21 and leptin in GDM patients,which may significantly affect the level of FGF21 in neonatal umbilical cord blood,and the level of FGF21 in neonatal umbilical cord blood is also associated with abnormal glucose and lipid metabolism in mothers.
Wang H , Li NH , Chivese T , et al . IDF diabetes atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group’s criteria [J ] . Diabetes Res Clin Pract , 2022 , 183 : 109050 .
Zhu YY , Zhang CL . Prevalence of gestational diabetes and risk of progression to type 2 diabetes:a global perspective [J ] . Curr Diab Rep , 2016 , 16 ( 1 ): 7 .
Wang SL , Liu YZ , Tam WH , et al . Maternal gestational diabetes mellitus associates with altered gut microbiome composition and head circumference abnormalities in male offspring [J ] . Cell Host Microbe , 2024 , 32 ( 7 ): 1192 - 1206 .
Ho M , Chul J . Gestational diabetes mellitus: diagnostic approaches and maternal-offspring complications [J ] . Diabetes Metab J , 2022 , 46 ( 1 ): 3 - 14 .
Rasmussen L , Knorr S , Antoniussen CS , et al . The impact of lifestyle,diet and physical activity on epigenetic changes in the offspring-a systematic review [J ] . Nutrients , 2021 , 13 ( 8 ): 2821 .
Geng LL , Lam KSL , Xu AM . The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic [J ] . Nat Rev Endocrinol , 2020 , 16 ( 11 ): 654 - 667 .
Fasshauer M , Blüher M , Stumvoll M . Adipokines in gestational diabetes [J ] . Lancet Diabetes Endocrinol , 2014 , 2 ( 6 ): 488 - 499 .
Pan Q , Lin SS , Li Y , et al . A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis [J ] . EBioMedicine , 2021 , 63 : 103202 .
Jimenez V , Jambrina C , Casana E , et al . FGF21 gene therapy as treatment for obesity and insulin resistance [J ] . EMBO Mol Med , 2018 , 10 ( 8 ): e8791 .
朱 丽 , 张 蓉 , 张淑莲 , 等 . 中国不同胎龄新生儿出生体重曲线研制 [J ] . 中华儿科杂志 , 2015 , 53 ( 2 ): 97 - 103 .
Zhu L , Zhang R , Zhang SL , et al . Chinese neonatal birth weight curve for different gestational age [J ] . Chin J Pediatr , 2015 , 53 ( 2 ): 97 - 103 .
Sweeting A , Wong J , Murphy HR , et al . A clinical update on gestational diabetes mellitus [J ] . Endocr Rev , 2022 , 43 ( 5 ): 763 - 793 .
Anna V , van der Ploeg HP , Cheung NW , et al . Sociodemographic correlates of the increasing trend in prevalence of gestational diabetes mellitus in a large population of women between 1995 and 2005 [J ] . Diabetes Care , 2008 , 31 ( 12 ): 2288 - 2293 .
Sauder KA , Ritchie ND . Reducing intergenerational obesity and diabetes risk [J ] . Diabetologia , 2021 , 64 ( 3 ): 481 - 490 .
吴佳丽 , 甘文佳 , 冯品宁 . 孕期血脂指标与妊娠期糖尿病及新生儿脐血C肽的相关性研究 [J ] . 新医学 , 2023 , 54 ( 7 ): 517 - 521 .
Wu JL , Gan WJ , Feng PN . Study of the correlation between serum lipid parameters during pregnancy and gestational diabetes mellitus and neonatal cord-blood C-peptide [J ] . J New Med , 2023 , 54 ( 7 ): 517 - 521 .
Voerman E , Santos S , Inskip H , et al . Association of gestational weight gain with adverse maternal and infant outcomes [J ] . Jama , 2019 , 321 ( 17 ): 1702 .
Tan HL , Yue T , Chen ZF , et al . Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine [J ] . Int J Biol Sci , 2023 , 19 ( 1 ): 66 - 88 .
党洪霞 . 血清FABP4、FGF21、Nesfatin-1与妊娠期糖尿病患者胰岛素抵抗的关系 [J ] . 中国妇幼保健 , 2017 , 32 ( 21 ): 5234 - 5236 .
Dang HX . Relationship between serum FABP4,FGF21,Nesfatin-1 and insulin resistance in patients with gestational diabetes mellitus [J ] . Matern Child Health Care China , 2017 , 32 ( 21 ): 5234 - 5236 .
李灵玲 , 李 卉 , 肖准 . 不同糖耐量孕妇血清FGF21水平与胰岛素功能关系 [J ] . 中国妇幼健康研究 , 2018 , 29 ( 1 ): 32 - 35 .
Li LL , Li H , Xiao Z . Relationship between serum FGF21 level and insulin function in pregnant woman with different glucose tolerance [J ] . Chin J Woman Child Health Res , 2018 , 29 ( 1 ): 32 - 35 .
Kampmann FB , Thuesen ACB , Hjort L , et al . Increased leptin,decreased adiponectin and FGF21 concentrations in adolescent offspring of women with gestational diabetes [J ] . Eur J Endocrinol , 2019 , 181 ( 6 ): 691 - 700 .
Post A , Dam WA , Sokooti S , et al . Circulating FGF21 concentration,fasting plasma glucose,and the risk of type 2 diabetes: results from the PREVEND study [J ] . J Clin Endocrinol Metab , 2023 , 108 ( 6 ): 1387 - 1393 .
Bawah AT , Seini MM , Abaka-Yawason A , et al . Leptin,resistin and visfatin as useful predictors of gestational diabetes mellitus [J ] . Lipids Health Dis , 2019 , 18 ( 1 ): 221 .
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621